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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe mechanisms regulating human embryonic stem (ES) cell self-renewal and differentiation are not well defined in part due to the lack
of tools for forward genetic analysis. We present a piggyBac transposon gain of function screen in human ES cells that identifies
DENND2C, which genetically cooperates withNANOG tomaintain self-renewal in the presence of retinoic acid.We show that DENND2C
negatively regulates RHOA activity, which cooperates withNANOG to block differentiation. It has been recently shown that RHOA exists
in the nucleus and is activated by DNA damage; however, its nuclear function remains unknown. We discovered that RHOA associates
with DNA and that DENND2C affects nuclear RHOA localization, activity, and DNA association. Our study illustrates the power of
piggyBac as a cost-effective, efficient, and easy to use tool for forward genetic screens in human ES cells and provides insight into the
role of RHOA in the nucleus.INTRODUCTION
Themolecular basis for the self-renewal and differentiation
of human embryonic stem (ES) cells is not fully under-
stood. In the mouse, self-renewal depends on the mainte-
nance of a core regulatory network of three transcription
factors, Nanog, Oct4, and Sox2, which function as a unit
to block differentiation (reviewed in Jaenisch and Young,
2008).Mouse embryos null for any of these factors are inca-
pable of maintaining a pluripotent inner cell mass, and
cells destined to become epiblast instead develop into
extraembryonic lineages (Avilion et al., 2003; Nichols
et al., 1998; Chambers et al., 2003; Mitsui et al., 2003).
The involvement of these transcription factors has been
more recently extended to human ES cells, as they occupy
the promoters of a number of genes shown to be differen-
tially upregulated or repressed in human ES cells versus
differentiated cells (Boyer et al., 2005). Unlike mouse ES
cells, these three factors do not function as a unit to regu-
late self-renewal of human ES cells and each represses the
differentiation of different cell fates (Wang et al., 2012).
Little is known about the factors working with either
NANOG, OCT4, or SOX2 to block lineage specific differen-
tiation in human ES cells. Co-immunoprecipitation exper-
iments have been successfully utilized to detect proteins
binding to and cooperating with Nanog, Oct4, and Sox2
in mouse ES cells (Wang et al., 2006; Liang et al., 2008;
van den Berg et al., 2010; Mallanna et al., 2010; Pardo
et al., 2010). We would like to develop a complementary
forward genetic approach to identify genes that cooperate
with a factor such as NANOG in regulating important bio-
logical processes in human ES cells. A forward genetic
approach not only has the power to interrogate the926 Stem Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The Authogenome in an unbiased fashion, but also has the potential
to identify cooperating genes that are either not in the
same protein complex or have low transcript or protein
abundance.
We have previously shown that the piggyBac (PB) trans-
poson modified from moth can efficiently transpose in
the mouse and human genomes (Ding et al., 2005). Here
we present a gain of function screen in human ES cells us-
ing PB transposonmutagenesis. The transposon is specially
designed for identifying genes that cooperate withNANOG
to block differentiation and support human ES cell self-
renewal. As proof of principle, we show that the screen
identified DENND2C, whose overexpression is capable of
genetic cooperation with NANOG to block retinoic
acid (RA)-induced differentiation. Further characterization
revealed that DENND2C negatively regulates RHOA,
affecting the localization, activity, and DNA association
of nuclear RHOA.RESULTS
PB Insertional Mutagenesis Screen in Human ES Cells
The PB transposon has been demonstrated to be a useful
tool for efficient transgenesis and insertional mutagenesis
in both mouse and human immortalized cells (Ding
et al., 2005). The transposon can efficiently mediate both
loss- and gain-of-function insertional mutagenesis in
mice (Ding et al., 2005; Rad et al., 2010; Landrette et al.,
2011). Given that PB can also mediate efficient gene trans-
fer in human ES cells (Chen et al., 2010), we decided to
develop a PB vector for insertional mutagenesis screens in
human ES cells.rs
Figure 1. PB Mutagenesis in OCT4 Re-
porter Human ES Cells
(A) Splicing consequences of PB[Insertional
Mutagenesis,NANOG] (PB[IM,N]) insertion
either in front of or within the intron of a
gene. PB[IM,N] insertion into any reading
frame is capable of inducing both over-
expression of the downstream transcript
with the b actin promoter and triple reading
frame start cassette (not shown) as well as
simultaneous expression of Katushka fluo-
rescent marker by the splicing of Katushka/
IRES into the native transcript with the
splice donor (SD). This construct is also
able to create N-terminally truncated tran-
scripts with the splice acceptor, triple
reading frame stop cassette, and poly A tail
(SA-stop-pA). PB[IM,N] can also constitu-
tively overexpress NANOG transcript from
the independent NANOG overexpression
cassette.
(B) (Top) FACS analysis of Katushka
expression from PB[IM,N] in human ES cells
48 hr after transfection in single-cell
suspension using the RFP channel. Mean
of triplicate independent experiments is
shown. Error bars represent SD. (Bottom) PB
copy number within ten individual PB
[IM,N] transfected human ES cell clones as
assessed by real time PCR. There is a mean of
five PB[IM,N] insertions per clone.
(C) Protocol of screen performed in H1
OCT4-EGFP cells for resistance to RA-
induced differentiation using PB[IM,N].
Cells in six-well plates were transfected with
PB[IM]N, puromycin selected, and subse-
quently treated with RA and G418. Cells
were then split from the six-well plates into
10-cm plates at a 2:1 ratio and maintained
on G418 alone.
(D) Brightfield and fluorescent images of the six unique clones recovered from the screen. All clones are positive for EGFP and Katushka
fluorescent reporters for OCT4 expression and PB[IM,N] insertion within an actively expressed gene.To identify factors that cooperate with NANOG to block
RA-induced differentiation, we have taken the advantage
of PB’s large cargo capacity to develop an insertional muta-
genesis vector that can simultaneously express theNANOG
transgene (PB[IM,N]; Figure 1A; Ding et al., 2005; Li et al.,
2011). PB[IM,N] insertion upstream of a gene results in
constitutive overexpression of the downstream gene, while
insertion within a transcription unit can result in overex-
pression of a truncated gene product downstream of the
insertion site, leading to constitutive activation, domi-
nant-negative effects, or heterozygous knockout of the
gene (Figure 1A). In addition to mutagenesis, such inser-
tions result in fluorescent labeling ofmutated cells with Ka-Stemtushkamarker. Upon co-transfection with a helper plasmid
carrying the PB transposase transgene, PB[IM,N] stably in-
tegrates into the genome of about 30% of transfected hu-
man ES cells with an average of five copies of transposon
per genome (Figure 1B; Experimental Procedures). Of 133
PB insertions mapped in human ES cells to date, 93% of in-
sertions are within 200 kb of a gene, and 53% are located
within an intron. This is consistent with data showing
that PB frequently integrates near to or within coding
units, making this transposon a useful tool for insertional
mutagenesis of genes (Ding et al., 2005). The puromycin
antibiotic resistance marker within the construct allows
for the selection of cells with stable PB integration. Thus,Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The Authors 927
this vector allows one to generate a library of individually
mutagenized human ES cells with the condition of
NANOG overexpression in a quick, easy, and cost-effective
fashion.
For this screen, we have used an H1 human ES cell line
containing an EGFP reporter and neomycin resistance
cassette knocked into the OCT4 30UTR (Zwaka and Thom-
son, 2003; H1 OCT4-EGFP or WT cells). Undifferentiated
cells that continue to express the self-renewal factor
OCT4 are both EGFP positive and G418 resistant. We
utilized PB[IM,N] to screen for genes capable of genetically
cooperating with NANOG to block differentiation of H1
OCT4-EGFP human ES cells. For the screen, approximately
9.6 3 107 cells were transfected in single-cell suspension
with PB[IM,N] and the PB transposase transgene plasmid
in 24 Matrigel-coated 6-well plates, allowing for the isola-
tion of individualmutant clones after puromycin selection.
Surviving adherent and puromycin selected cells were
subsequently treated with a combination of RA and G418
in the same monolayer culture. Six surviving independent
clones with undifferentiated morphology were isolated
and confirmed in retesting (Figure 1C; see Experimental
Procedures for details). All of these Katushka-positive
clones express OCT4-EGFP, indicating that they remain
undifferentiated (Figure 1D).
In human ES cells, the expression of a NANOG transgene
confers inhibition of spontaneous differentiation and
fibroblast growth factor (FGF) independence (Zhang
et al., 2009; Darr et al., 2006). In mouse ES cells, expression
of a Nanog transgene has been shown to confer several
effects, including resistance to RA-induced differentia-
tion, leukemia inhibitory factor (LIF) independence, and
increased colony formation (Chambers et al., 2003; Mitsui
et al., 2003; reviewed in Pan and Thomson, 2007). We
confirmed that expression of NANOG by a PB vector in
the H1 OCT4-EGFP cells stabilizes human ES cells to resist
spontaneous differentiation (PB[NANOG] or NANOG; Fig-
ure 2A). Unlike in mouse ES cells, NANOG overexpression
in human ES cells confers only weak resistance to RA-
induced differentiation. All WT human ES cells appear
morphologically differentiated in response to RA treatment
(Figure 2B). This differentiation is reflected by induction of
the GATA6 endoderm marker (Figures 2B and 2C). In
contrast, NANOG expressing colonies after RA treatment
contain small patches of cells that appear morphologically
undifferentiated and continue to express NANOG (Figures
2B and 2C). This weak resistance to RA is also observed in
cells transfected with the PB[IM,N] mutagenic construct
(Figure 2D). Concordant with these results, only a few PB
[NANOG] or PB[IM,N] colonies are able to survive when
RA treatment is combinedwithG418, as differentiated cells
no longer express the G418 resistance marker (Figure 2E).
Thus, NANOG overexpression in human ES cells offers an928 Stem Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The Authoideal condition for forward genetics, as the small degree
of resistance to differentiation allows for a sensitized screen
without the drawback of excessive background. The clones
identified from the screen display robust resistance to
RA treatment in comparison to NANOG overexpressing
escapers (Figure 2E). Indeed, only the identified clones
can survive more than one round of RA treatment.
The PB insertion sites in the resistant clones were deter-
mined by PCR and sequencing (Experimental Procedures;
Table S1). Detailed characterization of one of the isolated
clones is presented below, while other information will
be described elsewhere.
Identification of DENND2C as a NANOG Collaborator
for Blocking Differentiation
The clones isolated from the screen exhibit varying degrees
of blocking RA-induced differentiation and different mor-
phologies, suggesting different underlying mechanisms
of resistance (Figure 2E). Clone 2 was of particular interest
to us because of its unique morphology. Cells from this
clone resisted spontaneous differentiation and instead
piled into dense, multilayered colonies, with some cells
aggregating into balls. These cells exhibited a weak attach-
ment to Matrigel as they are readily detached after collage-
nase IV treatment. Clone 2 had three PB insertions, the
examination of which led to the identification of the
causative gene, DENND2C. DENND2C belongs to a family
of proteins containing DENN domains (Differentially Ex-
pressed in Normal versus Neoplastic; reviewed in Marat
et al., 2011). A PB insertion is located within an intron of
the DENND2C gene, resulting in the overexpression of
the C-terminal DENNdomain of the genewhile not having
significant effects on the expression of surrounding genes
(Figure 3A). More importantly, overexpression of the
DENND2C gene product alone, either truncated or full
length, in the NANOG-expressing parental cells pheno-
copies clone 2 morphology and behavior (Figure 3B). This
indicates that PB disruption of DENND2C is the causative
alteration (Figures 3A and 3B).
These cells maintain the expression of stemness markers
OCT4, NANOG, and alkaline phosphatase and are able to
form well-differentiated teratomas in mice, indicating
that they are undifferentiated (Figures 3C, 3D, and S1A).
DENND2Cexpressing cells are resistant to spontaneous dif-
ferentiation as well as several passages in RA-treatedmedia;
however, resistance is not observed with other differenti-
ating agents suchas12-O-Tetradecanoylphorbol-13-acetate
(TPA). Furthermore, the effects of DENND2C on colony
morphology were reversible in a doxycycline-inducible
system (data not shown).
By comparing cells overexpressing either DENND2C
alone or DENND2C expressed in the PB[NANOG] back-
ground, we discovered that DENND2C alone is responsiblers
Figure 2. NANOG Expression from PB Constructs Induces Resistance to RA-Induced Differentiation
(A) OCT4 immunostaining in WT and NANOG expressing human ES cells. NANOG expressing cells resist spontaneous differentiation and
maintain OCT4 signal in colony centers at larger diameters than WT cells. Scale bar represents 100 mm.
(B) (Top) Morphology of RA differentiated cells. The red square highlights a cluster of morphologically undifferentiated NANOG expressing
cells after RA treatment, magnified in inset. Scale bar represents 200 mm. (Bottom) RT-PCR analysis of RA-differentiated cells.
(C) Immunostaining of RA-differentiated cells co-stained for NANOG and GATA6. RA induces differentiation of human ES cells as assessed
by GATA6 endoderm marker. Scale bar represents 150 mm.
(D) Real-time PCR (top) and western blot (bottom) analysis of stemness marker expression in RA-treated cells. The addition of a NANOG
overexpression cassette to PB[IM] induces protein overexpression of both NANOG and the NANOG target OCT4 and induces weak
persistence of NANOG and OCT4 after RA treatment. Graph shows mean of triplicate independent experiments. Error bars represent SD.
**p < 0.001 in Student’s t test.
(E) Alkaline phosphatase staining of combined RA/G418-treated cells after 16 days. Experiments are performed in duplicate. A
representative plate is shown.
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Figure 3. PB Mutagenesis of DENND2C Causes Morphological Changes and Resistance to RA
(A) (Top) Screenshot from the UCSC Genome Browser detailing the position and orientation of the PB[IM,N] insertion in DENND2Cmapped
in clone 2 (red arrow). (Bottom right) PB[IM,N] insertion results in overexpression of the C-terminal half of DENND2C, made up primarily of
its DENN domain. (Bottom left) The C terminus of DENND2C is significantly upregulated in clone 2 by real-time PCR. Graph shows mean of
triplicate technical replicates, and error bars represent SD. **p < 0.001 in Student’s t test.
(B) Brightfield and OCT4-EGFP reporter images of clone 2 and DENND2C expressing human ES cells. Clone 2 aggregates into either balls of
cells or flat, extremely dense colonies that resist spontaneous differentiation. Cells stably transfected with full-length (FL) or truncated
(TR) DENND2C also display this behavior. Scale bar represents 50 mm.
(C) RT-PCR showing maintenance of stemness in DENND2C expressing human ES cells, which do not display markers of
differentiation.
(legend continued on next page)
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for the morphological properties of clone 2, while cooper-
ation of DENND2C and NANOG is responsible for block-
ing RA-induced differentiation (Figures 3B and 3E). This
genetic cooperation is also observed in induced pluripo-
tent stem cells co-expressing DENND2C and NANOG
(Figure S1B).
DENND2C Functions as a Negative Regulator of RHOA
and RAC1
DENN domain proteins have been shown to function as
RAB GEFs (GDP-GTP exchange factors) as well as interact
with non-RAB proteins (Allaire et al., 2010; Yoshimura
et al., 2010; reviewed in Marat et al., 2011). The DENND2
subfamily consists of four members, A through D. While
all four DENND2 subfamily members could behave as
RAB9 GEFs by in vitro GDP release activity, the in vivo
functions for DENND2B, DENND2C, and DENND2D are
unknown, as only DENND2A knockdown phenocopies
the lysosomal defect caused by RAB9 inactivation in HeLa
cells (Yoshimura et al., 2010). Consistent with the previous
report, we detected a lysosomal defect for DENND2A, but
not for DENND2C in knockdown experiments in human
ES cells (Figure S1C). Furthermore, deregulation of RAB9A
and B activities using dominant-negative and active mu-
tants does not result in any of the ES cell phenotypes
caused by DENND2C (Figure S1D). These data indicate
that DENND2C does not function as a regulator for RAB9
in human ES cells.
DENND2 proteins are expressed within the nucleus and
cytoplasm of both undifferentiated and differentiated
human ES cells (Figure S1E). While DENND2C knockdown
does not induce differentiation, it is possible that it shares
redundant functionwith other DENND2proteins.Wewere
unable to induce sufficient simultaneous knockdown of
DENND2 proteins to induce differentiation in human ES
cells.
We thus further examined the colony morphology
phenotype caused by DENND2C, as it could provide clues
for underlying molecular mechanisms. DENND2C-ex-
pressing colonies have a strikingly disorganized cortical
F-actin staining pattern, which differs from the organized
cortical F-actin pattern observed inWThumanES cells (Fig-
ure 4A). In addition, these cells are smaller in cell and
nuclear sizes, which is more dramatic toward the interior
of colonies (Figure 4A). Despite these morphological
changes, these cells remain actively proliferative with no(D) Western blot demonstrating that DENND2C overexpressing cells pro
WT and NANOG overexpressing cell lines. Overexpressed DENND2C-FL
running at the predicted 50 kDa of truncated DENND2C.
(E) Alkaline phosphatase-stained plates after RA/G418 treatment. Ex
each set of experiments is shown.
See Figure S1 for additional information.
Stemchanges in either DNA content or cell-cycle profile
compared with WT human ES cells (Figure S1F).
The striking cytoskeletal and morphological changes in
clone 2 and DENND2C-expressing cells suggested that
a cytoskeletal regulator could be the potential effector of
DENND2C. Thus, we tested components of several path-
ways regulating the cytoskeleton, cell size, and cell adhe-
sion by stably transfecting PB constructs containing WT,
dominant-negative, and constitutively active forms of
these genes intoWThuman ES cells. These candidate genes
were examined for morphologies similar to DENND2C
expressing cells as well as the ability to block RA-induced
differentiation when transfected into the PB[NANOG]
cell line. We discovered that reduction of RHOA and
RAC1 activities by the expression of dominant-negative
alleles, knockdown, or direct chemical inhibition could
recapitulate theDENND2C-expressing phenotypes. Down-
regulation of either RHOA or RAC1 causes the cells to pile
into dense, multilayer colonies (Figures 4B and S2A–S2F).
However, only downregulation of RAC1 results in cells
aggregating into balls (Figures 4B and S2A). Expression of
dominant-negative RAC1 (T17N, RAC1 DN) results in the
small cell and nuclei phenotypes observed in DENND2C-
expressing cells (Figure 4C). On the other hand, expression
of dominant-negative RHOA (T19N, RHOA DN) results
in altered F-actin morphology phenotypes (Figure 4C).
Expression of dominant-negative RHOB or RHOC (T19N)
does not elicit these morphological changes, instead
triggering differentiation (data not shown), indicating
that themorphological changes are specific to downregula-
tion of RHOA activity. Finally, similar to clone 2 and
DENND2C-expressing clones, cells with reduction of either
RHOA or RAC1 activity maintain the expression of stem-
ness markers (Figure S2G).
Although we were unable to test the effects of RAC1
disruption in blocking RA due to its suppression of prolifer-
ation, disruption of RHOA exhibits genetic cooperation
with NANOG expression in amanner similar to DENND2C
to block RA-induced differentiation (Figures 4D and
S2D). This genetic cooperation enhances NANOG-induced
repression of the endoderm differentiation trigger GATA6
(Figure 4E; Capo-Chichi et al., 2005; Cai et al., 2008).
As it has been shown that chemical inhibition of the
RHOA effector ROCK with the drug Y-27632 (ROCK inhib-
itor) results in resistance to RA, we wondered whether
ROCK inhibitor treatment of NANOG expressing cellsduce NANOG and OCT4 proteins at levels comparable to the parental
runs as a doublet, while only DENND2C-TR lysate exhibits a band
periments were performed in triplicate. A representative plate for
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Figure 4. DENND2C Phenotype Is Induced by Loss of Active RHOA and RAC1
(A) DAPI and F-actin immunostaining of WT and DENND2C expressing human ES cells. Scale bar represents 30 mm.
(B) Brightfield and OCT4-EGFP reporter images of cells stably expressing dominant-negative RHOA T19N (RHOA DN) and dominant-negative
RAC1 T17N (RAC1 DN). Scale bar represents 50 mm.
(C) DAPI and F-actin immunostaining of WT and RHOA DN and RAC1 DN mutant human ES cells. Scale bar represents 30 mm.
(D) Plates stained for alkaline phosphatase after RA/G418 treatment. Experiments were performed in triplicate. A representative plate for
each set of experiments is shown.
(E) The induction of lineage markers with RA assessed by real-time PCR. RA treatment induces differentiation as reflected by
the induction of the endoderm marker GATA6. NANOG expression from PB induces some repression of GATA6 and no upregulation
of endogenous NANOG. NANOG/DENND2C and NANOG/RHOA DN cells display enhanced repression of GATA6 and upregulation of
(legend continued on next page)
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could block RA-induced differentiation (Krawetz et al.,
2011). However, unlike Rho inhibitor treatment, ROCK in-
hibitor treatment does not cooperatewithNANOG to block
RA-induced differentiation (Figures 4D and S2D). Given
that NANOG overexpression also results in the overexpres-
sionof its targetOCT4,we furtherwonderedwhetherOCT4
overexpression could cooperate with RHOA disruption to
block RA-induced differentiation. However, this was not
the case (Figure S2H). These results indicate that our
approach of NANOG sensitized PB mutagenesis is useful
in identifying relevant genetic interactions with NANOG
capable of blocking RA-induced differentiation.
InactivationofRHOAandRAC1 recapitulatesDENND2C-
expressing phenotypes and suggests that DENND2C could
be a negative regulator of RHOA and RAC1. We next exam-
ined thepossibility thatDENND2Cphysically interactswith
RHOA and RAC1; however, we did not detect such interac-
tions by co-immunoprecipitation (data not shown). We
thus directly examined the activities of RHOA and RAC1
in human ES cells expressing either full-length or truncated
DENND2C by immunoprecipitation of the active forms of
these GTPases. Indeed, in both cases, overexpression of
DENND2C results in decreased levels of active RHOA and
RAC1 (Figure 4F).
DENND2C Affects Nuclear RHOA Function
Given that DENND2C negatively regulates RHOA activity,
we examined whether DENND2C expression affected
RHOA localization. Interestingly, while WT cells displayed
RHOA staining throughout the cell, in DENND2C express-
ing cells, RHOA was relocalized away from the interior of
the nucleus (Figure 5A). Although RHOA plays an essential
role in the regulation of cytoskeleton dynamics, many of
the known functions of RHOA relate to its functions in
the cytoplasm (reviewed in Burridge and Doughman,
2006). RHOA has been recently documented to reside in
the nucleus (Dubash et al., 2011). In fact, actin and many
actinnucleators have also been found in thenucleus, impli-
cating functional significance for the nuclear cytoskeleton
(reviewed in de Lanerolle, 2012; Weston et al., 2012; Hof-
mann, 2009). While it has been shown that nuclear
RHOA is activated in response to DNA damage, its function
within thenucleus remains unknown (Dubash et al., 2011).
We therefore examined whether DENND2C affected the
localization and activity of nuclear RHOA. By immuno-
staining human ES cell nuclei isolated by density gradientendogenous NANOG at the RNA level. Graph shows mean of triplicat
*p < 0.05 in Student’s t test.
(F) Immunoprecipitation of active RHOA and RAC1 in DENND2C express
RAC1 relative to WT cells.
See Figure S2 for additional information.
Stemcentrifugation, it was evident thatWTandNANOGoverex-
pressing cells contained RHOA throughout the nucleus
(Figure 5B). In contrast, RHOA in DENND2C overexpress-
ingnuclei is relocalized to thenuclear periphery (Figure 5B).
We next examined the activity of RHOA in nuclear and
cytoplasmic fractions of WT and DENND2C expressing
human ES cells (Guilluy et al., 2011). In addition to reduced
cytoplasmic RHOA activation, DENND2C expressing
cells have significant reduction of nuclear RHOA activation
(Figure 5C). We observed similar reduction of active nu-
clear RHOA in the RHOA DN-expressing positive control
(Figure 5C).
As a negative control, we expressed RAB35 in human ES
cells, which has been implicated in the cytoplasmic trans-
port and regulation of Rho GTPases (Chevallier et al.,
2009; Shim et al., 2010). Indeed, expression of RAB35 in-
hibits cytoplasmic RHOA activity, but not nuclear RHOA
activity, nor does RAB35 expression result in cooperation
with NANOG in blocking RA-induced differentiation (Fig-
ures 5C and S3A–S3E). Furthermore, the expression of
RHOA DN tagged with a nuclear exclusion signal does
not cooperate with NANOG to block differentiation (Fig-
ure S3F). Together, our data suggest that DENND2C down-
regulates both nuclear and cytoplasmic RHOA activity,
which cooperates withNANOG to block RA-induced differ-
entiation. Indeed, nuclear RHOA is hyperactivated during
RA-induced differentiation ofWT human ES cells, support-
ing this hypothesis (Figure S3G).
Given that DENND2C negatively regulates nuclear
RHOA, we wondered what function RHOA had within
the nucleus. Other cytoskeletal effectors are known to asso-
ciate with DNA either globally or with certain promoters
when activated, and furthermore, nuclear RHOA is acti-
vated in response to DNA damage (Mazumdar et al.,
2011; Buongiorno et al., 2008; Dubash et al., 2011).
We therefore hypothesized that nuclear RHOA may asso-
ciate with DNA. Using chromatin immunoprecipitation
(ChIP) with an anti-RHOA monoclonal antibody that
works well for immunoprecipitation (Figure S3H), we
were able to pull down large amounts of DNA in undiffer-
entiated WT and NANOG expressing human ES cells (Fig-
ure 5D). In contrast, the amount of DNA associated with
RHOA in DENND2C overexpressing human ES cells is
dramatically reduced (Figure 5D). The RHOA-precipitated
DNA includes the OCT4 and GATA6 promoters, DNA
from a gene desert located on chromosome 13, as well ase independent experiments. Error bars represent SD. **p < 0.001,
ing cells. DENND2C expressing cells have decreased active RHOA and
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Figure 5. DENND2C Negatively Regulates Nuclear RHOA Activities
(A) DAPI and RHOA immunostaining of WT and DENND2C expressing ES cell colonies. Scale bar represents 10 mm.
(B) DAPI and RHOA immunostaining of isolated WT and DENND2C expressing nuclei. Scale bar represents 3 mm.
(C) Immunoprecipitation of active RHOA from nuclear and cytoplasmic fractions of WT and mutant cells. DENND2C and RHOA DN cells have
reduced active RHOA in both nuclear and cytoplasmic fractions. Cytoplasmic RHOA inhibitor (RAB35) is included as a negative control.
(D) ChIPs performed in human ES cells with a RHOA monoclonal antibody and NANOG-positive control antibody. Presented is the average
fold enrichment over IgG control of the OCT4 promoter, GATA6 promoter, chromosome 13 gene desert, and a satellite DNA. Error bars
represent the mean percent fold enrichment over IgG control ± the SEM for triplicate technical replicates.
See Figure S3 for additional information.centromeric a satellite DNA, indicating that RHOA does
not exclusively associate with transcription units (Fig-
ure 5D). RHOA association with DNA was also confirmed
in other human ES cell lines (H9 and parental H1; Fig-
ure S3I). Overall, these data show that nuclear RHOA asso-
ciates with chromatin in ES cells and that this ability is
affected upon downregulation of nuclear RHOA activity
by DENND2C.934 Stem Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The AuthoDISCUSSION
Todate, only one genome-wide genetic screenhas beenper-
formed in human ES cells (Chia et al., 2010). The high cost
associated with an siRNA library can deter investigators
from utilizing this approach to decipher human stem cell
biology. In this study,we show that the piggyBac transposon
can be used to conduct genetic screens in human ES cells.rs
The ability to rapidly and cost-effectively generate a large
collection of cells in which each cell has different genes
mutated by simple transfection enables one to perform
phenotypic-based genetic screens in human cells in a
manner similar to yeast genetics. Combined with high-
throughput sequencing, the genes disrupted by the piggy-
Bac transposon can be easily identified, allowing one to
study themolecularmechanisms underlying any biological
process.
The unique ability of the piggyBac transposon to carry
large inserts offers the opportunity to conduct sophisti-
cated insertional mutagenesis screens (Ding et al., 2005;
Li et al., 2011). Here we were able to combine mutagenesis
and simultaneous overexpression of a gene into a single
transposon vector, performing a genetic screen in a sensi-
tized background. Different from proteomic approaches,
this sensitized screening strategy has the power to detect
genes that cooperate in a biological process, e.g., blocking
differentiation, regardless whether gene products physi-
cally interact with each other. With this strategy, we are
able to probe the genome for genes capable of cooperating
with NANOG, and by characterizing one of the clones,
we were able to identify a poorly characterized gene,
DENND2C, which is capable of cooperation with NANOG
overexpression to block RA-induced differentiation.
Although our piggyBac screen utilizes gain-of-function
mutagenesis, such mutations can easily lead to the identi-
fication of loss-of-function alterations in genes in the
same pathway or process, as every pathway has both
positive and negative regulatory components. Indeed,
we discovered that DENND2C is a negative regulator of
RHOA. Concordantly, RHOA inactivation also cooperates
with NANOG in blocking RA-induced differentiation.
Although DENND2C was artificially overexpressed, we
were able to phenocopy its effects with several different
methods of RHOA inactivation, demonstrating that gain-
of-function screens can be used to elucidate real biological
mechanisms. Notably, both RHOA and DENND2C are
expressed in human ES cells as well as differentiated cells
and would have been missed as potential regulators of
self-renewal and differentiation by more traditional
approaches that focused on probing genes expressed
uniquely in ES cells. Much of our understanding of
RHOA comes from studies for its role in the cytoplasm as
a key regulator of cytoskeleton dynamics (reviewed in Bur-
ridge and Doughman, 2006). Recently, RHOA has been
found to be located within the nucleus, and its nuclear ac-
tivity is stimulated by DNA damage (Dubash et al., 2011).
We found that DENND2C negatively regulates the activity
of nuclear RHOA in human ES cells. Furthermore, we
discovered that nuclear RHOA is associated with DNA in
both coding and non-coding regions and that this associa-
tion is negatively regulated by DENND2C.StemIn summary, forward genetic analysis by piggyBac gain
of function mutagenesis has multiple advantages com-
plimenting genomic and biochemical methods and em-
powers individual investigators to functionally interrogate
the human ES cell genome to elucidatemechanisms under-
lying biology, disease, and therapeutic strategy.EXPERIMENTAL PROCEDURES
Cell Culture
The H1 OCT4-EGFP human ES cell line was created in the James
Thomson laboratory and obtained from the WiCell Research
Institute under the appropriate material transfer agreement
(MTA). Cells were maintained on Matrigel (BD Biosciences catalog
number 354277) in a 37C incubator at 5% CO2. Cells were
passaged with manual dissociation with a 5-ml pipette after
collagenase IV treatment (GIBCO catalog number 17104019) and
maintained as originally described (Thomson et al., 1998). Addi-
tional information is in Supplemental Experimental Procedures.
Transfections and Drug Selection
For the screen, 9.6 3 107 human ES cells were pretreated with
ROCK inhibitor as described (EMD/Calbiochem catalog number
688000; Watanabe et al., 2007) for 3 hr, dissociated with Accutase
(Millipore catalog number SCR005), and split in single-cell suspen-
sion onto Matrigel coated six-well plates. Each well was treated
with a cocktail consisting of 3-mg piggyBac, 1-mg PB transposase
helper plasmid, 6-ml Fugene HD (Roche catalog number
04883560001), and 90-ml OptiMEM (Invitrogen catalog number
11058-021) for 48 hr. Cells containing stable piggyBac integration
were selected with 1-mg/ml puromycin (Sigma catalog number
P8833) starting 48 hr after transfection for a period of 2 weeks.
For transfections of all other piggyBac constructs, adherent hu-
man ES cells 2 days after passaging were treated with the same
transfection cocktail and drug selection protocol.
RA Treatment
Human ES cells at approximately 30% confluency in six-well
plates were treated with a combination of 1-mM all-trans RA
(Sigma catalog number R2625) and 0.2-mg/ml G418 (Sigma cata-
log number A1720) for 8 days. Cells were then split into 10-cm
plates at a ratio of two wells to one 10-cm plate. Cells were kept
on G418 for another 8 days. For the screen, surviving undifferen-
tiated colonies were individually isolated from the 10-cm plates,
expanded, and retested for RA resistance. Of an initial 50 colonies
isolated, only six unique clones survived this retest. For assaying
resistance to differentiation, 10-cm plates were stained for the
stemness marker alkaline phosphatase (Millipore catalog number
SCR004).
Mapping of Insertions
Mapping was performed with a combination of linker-mediated
PCR as described in Landrette et al. (2011), splinkerette PCR as
described in Potter and Luo (2010) and Horn et al. (2007), and
vectorette PCR as described by Carl Friddle (available at http://
www.princeton.edu/genomics/botstein/protocols/vectorette.html).Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The Authors 935
PCR products created with Taq polymerase (Denville catalog num-
ber CB4050) were TOPO-TA cloned (Invitrogen catalog number
450641), and competent cells were transformed with the resulting
plasmid DNA. Individual bacterial colonies carrying an insert were
picked, expanded, and DNA isolated and sequenced through the
Yale Keck Sequencing Facility. True insertions were separated
from PCR artifacts by the identification of PBL next to the TTAA
transposition site within the sequence. Sequences identified by
PCRwere used to identify the location and orientation of the trans-
poson within the genome through human BLAT search (http://
genome.ucsc.edu/). Additional information is in Supplemental
Experimental Procedures.Reverse Transcription and PCR
Equal amounts of total RNA was reverse transcribed using Super-
script III and oligo(dT)20 (Invitrogen catalog number 18080-051).
On column DNase treatment was performed as described in the
instructionmanual. Semiquantitative PCRwas carried out in accor-
dance with the protocol used by Darr et al. (2006). Quantitative
real-time PCR was carried out on the cDNA using SYBR Green
Supermix (Bio-Rad catalog number 172-5100). Samples were
normalized to GAPDH amplification. Primer sequences available
in Supplemental Experimental Procedures.Active GTPase Immunoprecipitation
Immunoprecipitation of total active RHOA from350-mgwhole-cell
lysate was performed with the NewEast Biosciences RhoA Activa-
tion Assay (catalog number 80601). Immunoprecipitation of active
RHOA from 350-mg fractionated nuclear and cytoplasmic lysates
isolated as described in Guilluy et al. (2011) was performed with
the Cell Biolabs RhoA Activation Assay (catalog number STA-
403-A). Immunoprecipitation of active RAC1 from 500-mg whole-
cell lysate was performed with the Cell Biolabs Rac1 Activation
Assay (catalog number STA-401-1).Nuclear Isolation
The protocol is as described in Guilluy et al. (2011).Overexpression and Mutant Constructs
All genes overexpressed in human ES cells were amplified from
either human ES cell or 293T cDNA created with the Superscript
III kit (Invitrogen catalog number 18080-051) with the excep-
tions of NANOG, which was amplified from Addgene plasmid
16578, a gift from Dr. James Thomson, and RHOA, which was
amplified off Addgene plasmid 23224, a gift from Dr. Channing
Der. All cDNA was amplified with MluI restriction sites and
cloned into a piggyBac construct designed to stably overexpress
the cloned gene with a b actin promoter with the sole exception
of NANOG, which was overexpressed with the ubiquitin C pro-
moter in all PB constructs used in this study. Dominant-negative
and constitutively active constructs were created by introducing
the mutations on primers and subsequent subcloning of
PCR products. For assessment of cooperation with NANOG, all
constructs were transfected into the same parental NANOG over-
expressing cell line. Primer sequences are available in Supple-
mental Experimental Procedures.936 Stem Cell Reports j Vol. 4 j 926–938 j May 12, 2015 j ª2015 The AuthoChIP
ChIP was performed using reagents from the Pierce Agarose
ChIP kit (Pierce catalog number 26156), MagnaChIP Protein AG
Beads (Millipore catalog number 16-663), and 6 3 106 cells
(approximately two to three 10-cm plates of human ES cells) per
immunoprecipitation. For each chip, we used either 2-mg NANOG
antibody or rabbit IgG control (Cell Signaling catalog numbers
5232S and 2729S) or 5-mg RHOA antibody (Abcam catalog number
ab54835) or mouse IgG control (Cell Signaling catalog number
5415S). Fresh chromatin and fresh antibody were incubated with
20-ml magnetic beads overnight at 4C. Eluted chromatin was
treated with RNase for 30 min prior to decrosslinking and column
purification. Real-time PCR was performed in triplicate on precip-
itated DNA with OCT4 promoter primers (Cell Signaling catalog
number 4641S), GATA6 promoter primers, gene desert primers
(Supplemental Experimental Procedures), and a satellite repeat
primers (Cell Signaling catalog number 4486S). For fold enrich-
ment calculations, the average percentage of input DNA pulled
downwithNANOG, or RHOA antibodywas divided by the average
percentage of input DNA pulled down with the relevant IgG
isotype control.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, three figures, and one table and can be found with this
article online at http://dx.doi.org/10.1016/j.stemcr.2015.03.001.ACKNOWLEDGMENTS
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